359 related articles for article (PubMed ID: 34210299)
21. Cannabidiol or CBD Oil: Help, Hope, and Hype for Psychiatric and Neurologic Conditions.
Newton M; Newton DW
J Am Psychiatr Nurses Assoc; 2020; 26(5):447-457. PubMed ID: 32508204
[No Abstract] [Full Text] [Related]
22. Usage and health perception of cannabidiol-containing products among the population in Germany: a descriptive study conducted in 2020 and 2021.
Geppert J; Lietzow J; Hessel-Pras S; Kirsch F; Schäfer B; Sachse B
BMC Public Health; 2023 Nov; 23(1):2318. PubMed ID: 37996800
[TBL] [Abstract][Full Text] [Related]
23. Cannabidiol and Other Cannabinoids: From Toxicology and Pharmacology to the Development of a Regulatory Pathway.
Koturbash I; MacKay D
J Diet Suppl; 2020; 17(5):487-492. PubMed ID: 32715797
[TBL] [Abstract][Full Text] [Related]
24. Assessment of hemp oil-based cannabidiol use in a community-based pharmacy setting.
Gicewicz E; Gatewood SS; Kaefer TN; Nadpara P; Goode JR
J Am Pharm Assoc (2003); 2021; 61(4S):S49-S56. PubMed ID: 33745856
[TBL] [Abstract][Full Text] [Related]
25. The Trouble with CBD Oil.
Hazekamp A
Med Cannabis Cannabinoids; 2018 Jun; 1(1):65-72. PubMed ID: 34676324
[TBL] [Abstract][Full Text] [Related]
26. Labeling of Cannabidiol Products: A Public Health Perspective.
Corroon J; MacKay D; Dolphin W
Cannabis Cannabinoid Res; 2020; 5(4):274-278. PubMed ID: 33381640
[No Abstract] [Full Text] [Related]
27. Patterns and correlates of cannabidiol product and marijuana co-use in a sample of U.S. young adults.
Dunbar MS; Seelam R; Tucker JS; Firth CL; Pedersen ER; Klein DJ; Rodriguez A; D'Amico EJ
Addict Behav; 2022 Mar; 126():107185. PubMed ID: 34839070
[TBL] [Abstract][Full Text] [Related]
28. Heavy metal and phthalate contamination and labeling integrity in a large sample of US commercially available cannabidiol (CBD) products.
Gardener H; Wallin C; Bowen J
Sci Total Environ; 2022 Dec; 851(Pt 1):158110. PubMed ID: 35987236
[TBL] [Abstract][Full Text] [Related]
29. Product labeling accuracy and contamination analysis of commercially available cannabidiol product samples.
Gidal BE; Vandrey R; Wallin C; Callan S; Sutton A; Saurer TB; Triemstra JL
Front Pharmacol; 2024; 15():1335441. PubMed ID: 38562466
[No Abstract] [Full Text] [Related]
30. Cannabidiol Product Dosing and Decision-Making in a National Survey of Individuals with Fibromyalgia.
Boehnke KF; Gagnier JJ; Matallana L; Williams DA
J Pain; 2022 Jan; 23(1):45-54. PubMed ID: 34214700
[TBL] [Abstract][Full Text] [Related]
31. Regulatory Status of Cannabidiol in the United States: A Perspective.
Corroon J; Kight R
Cannabis Cannabinoid Res; 2018; 3(1):190-194. PubMed ID: 30283822
[TBL] [Abstract][Full Text] [Related]
32. Cannabidiol: pharmacology and therapeutic targets.
Britch SC; Babalonis S; Walsh SL
Psychopharmacology (Berl); 2021 Jan; 238(1):9-28. PubMed ID: 33221931
[TBL] [Abstract][Full Text] [Related]
33. The Role of Cannabidiol (CBD) in Chronic Pain Management: An Assessment of Current Evidence.
Boyaji S; Merkow J; Elman RNM; Kaye AD; Yong RJ; Urman RD
Curr Pain Headache Rep; 2020 Jan; 24(2):4. PubMed ID: 31980957
[TBL] [Abstract][Full Text] [Related]
34. Benefits, toxicity and current market of cannabidiol in edibles.
Astray G; Mejuto JC; Xiao J; Simal-Gandara J
Crit Rev Food Sci Nutr; 2023; 63(22):5800-5812. PubMed ID: 34989307
[TBL] [Abstract][Full Text] [Related]
35. Cannabidiol use and effectiveness: real-world evidence from a Canadian medical cannabis clinic.
Rapin L; Gamaoun R; El Hage C; Arboleda MF; Prosk E
J Cannabis Res; 2021 Jun; 3(1):19. PubMed ID: 34162446
[TBL] [Abstract][Full Text] [Related]
36. Respiratory depression following an accidental overdose of a CBD-labeled product: A pediatric case report.
Herbst J; Musgrave G
J Am Pharm Assoc (2003); 2020; 60(1):248-252. PubMed ID: 31767538
[TBL] [Abstract][Full Text] [Related]
37. Cannabis retailer marketing strategies and regulatory compliance: A surveillance study of retailers in 5 US cities.
Berg CJ; Romm KF; Pannell A; Sridharan P; Sapra T; Rajamahanty A; Cui Y; Wang Y; Yang YT; Cavazos-Rehg PA
Addict Behav; 2023 Aug; 143():107696. PubMed ID: 36966547
[TBL] [Abstract][Full Text] [Related]
38. Clinicians' Guide to Cannabidiol and Hemp Oils.
VanDolah HJ; Bauer BA; Mauck KF
Mayo Clin Proc; 2019 Sep; 94(9):1840-1851. PubMed ID: 31447137
[TBL] [Abstract][Full Text] [Related]
39. Source of cannabinoids: what is available, what is used, and where does it come from?
Specchio N; Pietrafusa N; Cross HJ
Epileptic Disord; 2020 Jan; 22(S1):1-9. PubMed ID: 31941643
[TBL] [Abstract][Full Text] [Related]
40. The Impact of Cannabidiol on Psychiatric and Medical Conditions.
Oberbarnscheidt T; Miller NS
J Clin Med Res; 2020 Jul; 12(7):393-403. PubMed ID: 32655732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
